
David G. Armstrong Tapped to Lead Lakewood-Amedex Nu-3 Clinical Trial
Sarasota-based Lakewood-Amedex Biotherapeutics has appointed Dr. David G. Armstrong, a distinguished surgeon and professor at the Keck School of Medicine of USC, to serve as Study Chair for its Phase 2a clinical trial of Nu-3, an experimental topical gel targeting infected diabetic foot ulcers.





















